<DOC>
	<DOCNO>NCT00086346</DOCNO>
	<brief_summary>The purpose study evaluate sirolimus conversion regimen compare calcineurin inhibitor continuation regimen regard renal function stable liver transplant subject .</brief_summary>
	<brief_title>Study Evaluating Calcineurin Inhibitor Sirolimus ( Rapamune ) Treatment Liver Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>Age great 13 year ( age great 18 year require local regulation ) . Receiving immunosuppressive therapy calcineurin inhibitor ( CI ) +/ corticosteroid +/ antimetabolite . 6 144 month orthotopic liver transplantation . CockcroftGault GFR value ≥40 mL/min ≤90mL/min screen History nonhepatic transplantation Evidence systemic infection ( sepsis , bacteremia , pneumonia etc ) . Known suspected malignancy &lt; 5 year random assignment .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Liver</keyword>
	<keyword>Transplant</keyword>
</DOC>